Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 7,887 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Presence of High Intracranial Pressure
Interventions: EVD; Device
Lead sponsor: HeadSense Medical; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Miami, Florida • Baltimore, Maryland • Cleveland, Ohio

Conditions: Low Back Pain
Interventions: Clinical Practice Guidelines and Psychologically Informed Physical Therapy training/audit/feedback; Behavioral
Lead sponsor: Sara Gorczynski; Federal
Eligibility: 18 Years and older
Enrollment: 4,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Patient Satisfaction
Interventions: Telehealth 2 week postoperative visit; Other
Lead sponsor: Jackson, Elisha; Other
Eligibility: 18 Years and older · Female only
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Bacterial Vaginosis, Vaginal Flora Imbalance
Interventions: Flourish Vaginal Care System; Combination Product
Lead sponsor: Vaginal Biome Science; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Concord, New Hampshire

Conditions: Alzheimer&Amp;#39;s Disease-related Dementia, Alzheimer Disease, rTMS Stimulation
Interventions: Brain Stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 65 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 2 Diabetes Mellitus
Interventions: Carbohydrate-restricted diet, Mindfuless; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic, Amblyopia Strabismic
Interventions: Valproate, Placebo, Patch; Drug · Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Graft-versus-host Disease (GVHD)
Interventions: Ruxolitinib, Extracorporeal photopheresis (ECP), Low-dose methotrexate (MTX), Mycophenolate mofetil (MMF), mechanistic Target of Rapamycin (mTOR) inhibitors (everolimus or sirolimus), Infliximab, Rituximab, Pentostatin, Imatinib, Ibrutinib; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 12 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 38
States / cities: Tucson, Arizona • Duarte, California • La Jolla, California + 28 more

Conditions: Parent Child Relationship, Parenting Intervention, Parenting Behaviour, Interparental Conflict, Feasibility Study, Acceptability, Appropriateness, Child Mental Health
Interventions: New Beginnings Podcast Program, No Interventions; Behavioral · Other
Lead sponsor: Charla Aubrey Rhodes; Other
Eligibility: 8 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Hypertension
Interventions: Core intervention (Fitbit tracking and BP health education), Aerobic training (AT), Dynamic resistance training (DRT), Isometric resistance training (IRT); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 44 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Stent Occlusion
Interventions: Optical coherence tomography; Device
Lead sponsor: North Texas Veterans Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Health Coaching; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 95 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Myelogenous Leukemia
Interventions: Interventions; Device
Lead sponsor: Miltenyi Biotec B.V. & Co. KG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 3
States / cities: Chicago, Illinois • Minneapolis, Minnesota • Columbus, Ohio

Conditions: Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Interventions: High-dose Methotrexate; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 7 Years to 22 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 9
States / cities: Chapel Hill, North Carolina • Charlotte, North Carolina • Durham, North Carolina + 5 more

Conditions: Acute Pain, Surgery
Interventions: NeuroIDgenetix Test Panel; Other
Lead sponsor: AltheaDx; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Substance Use Disorders, Overdose, Opioid Use Disorder, Alcohol Use Disorder
Interventions: Substance Misuse Assistance Response Team (SMART), Usual Care Group; Behavioral · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Smoking Cessation, Alcohol Drinking
Interventions: Nicotine Replacement Therapy, Bupropion, Cognitive Behavioral Treatment, Mobile Contingency Management, Mobile Monitoring; Other · Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Achalasia
Interventions: Peroral Endoscopic Myotomy a less invasive treatment for Achalasia; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer, Gut Microbiome, Exercise, Fatigue
Interventions: Aerobic Exercise Training, Attention Control; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 74 Years · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Contraception
Interventions: Kyleena; Drug
Lead sponsor: Bayer; Industry
Eligibility: Female only
Enrollment: 1,134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 12
States / cities: Lakewood, Colorado • Sarasota, Florida • Wellington, Florida + 9 more

Conditions: Limbal Stem Cell Deficiency
Interventions: Non-interventional; Other
Lead sponsor: Claris Biotherapeutics, Inc.; Industry
Eligibility: 12 Years to 99 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 8
States / cities: Carmel, Indiana • Indianapolis, Indiana • Overland Park, Kansas + 5 more

Conditions: Crohn's Disease
Interventions: Not listed
Lead sponsor: AbbVie; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 1,446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 45
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 36 more

Conditions: Childhood Obesity
Interventions: Primary (Environmental) Weight Gain Prevention, Secondary (Behavioral) Weight Gain Prevention, Control; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: Not listed
Enrollment: 2,060 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: HIV Infections
Interventions: SAIA-HIV-SSP; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device

Resolving the Burden of Low Back Pain in Military Service Members and Veterans: A Pragmatic Clinical Trial

Telehealth Postop Follow up RCT

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

(R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger

Valproate for the Treatment of Residual Amblyopia

A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

The New Beginnings Podcast: Brief Audio Intervention for Parents From Divorced and Separated Families

A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control

Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery

Aides in Respiration Health Coaching for COPD

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures

Emergency Medicine Peer Outreach Worker Engagement for Recovery

Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking

The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia

Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

The Louisiana (LA) Health Project

A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services Programs